Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00465829 · ClinicalTrials.gov registry record

Long-term Effects of Bariatric Surgery

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
2,458
Enrollment target

NCT00465829: Completed study, sponsored by University of Pittsburgh.

NCT00465829 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 2,458 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00465829 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
2,458 participants
Enrollment target

Study Summary

The primary objective of LABS-2 is to use standardized techniques and measures to assess the longer-term safety and efficacy of bariatric surgery by: 1. comparing post-surgical outcomes to pre-operative status 2. examining risks and benefits of surgery. LABS-2 will determine the associations between clinical/demographic patient characteristics, components of the surgical procedure, and peri-operative and post-operative care with post-operative risks and changes in patient status. Funds are not available to pay for the surgery for patients, only to address research questions.

Trial Details

FieldValue
Enrollment Target 2,458 participants
Start Date 2006-03
Est. Completion 2016-06
University of Pittsburgh

1,238 total trials

What the finished NCT00465829 record still lists

NCT00465829 is an observational study that tracks outcomes without assigning an intervention. Its 2,458 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00465829 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00465829 about?

NCT00465829 is a clinical study titled "Long-term Effects of Bariatric Surgery". The primary objective of LABS-2 is to use standardized techniques and measures to assess the longer-term safety and efficacy of bariatric surgery by: 1. comparing post-surgical outcomes to pre-operative status 2. examining risks and benefits of surgery. LABS-2 will determine the associations betwe...

What is the current status of trial NCT00465829?

This trial is currently completed. The enrollment target is 2,458 participants. The study started on 2006-03. Estimated completion is 2016-06.

Who is sponsoring clinical trial NCT00465829?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06898593 · 2,448 participants · NA

    Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients

  • NCT06128304 · 2,436 participants · NA

    ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

  • NCT06676904 · 2,433 participants · NA

    Neonatal Platelet Transfusion Threshold Trial

  • NCT05345951 · 2,425 participants · NA

    Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00465829, the US trial registry maintained by the National Library of Medicine. NCT00465829 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.